Concepedia
Statistics
Publications
9
Citations
327
H-Index
Active since
1947
Affiliations
Covance (United Kingdom)(Current)
British American Tobacco (United Kingdom)
Mark Ballantyne is an author at Covance (United Kingdom) specializing in toxicology, pharmacy, and mutagenicity assessment.
Publications per year
1947–2023
MNT and Muta™Mouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU
Elmar Gocke, Mark Ballantyne, James Whitwell et al. · Toxicology Letters · 2009 · 66 citations
Pharmacy, Toxicology, Dose-response Modeling +12
The Molecular Weight of Lysozyme Determined by the X-Ray Diffraction Method
K. J. Palmer, Mark Ballantyne, James Galvin · Journal of the American Chemical Society · 1948 · 55 citations
Life Sciences, Biochemistry, Chemistry +10
In vitro genotoxicity of para-phenylenediamine and its N-monoacetyl or N,N′-diacetyl metabolites
Jean‐Luc Garrigue, Mark Ballantyne, T. S. Kumaravel et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2006 · 52 citations
Pharmacy, Pharmacology, Toxicology +8
The mutagenic assessment of mainstream cigarette smoke using the Ames assay: A multi-strain approach
David Thorne, Joanne Kilford, M. Hollings et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2015 · 41 citations · Full text
Pharmacy, Toxicology, Environmental Toxicology +12
The effect of long term storage on tobacco smoke particulate matter in in vitro genotoxicity and cytotoxicity assays
Ian Crooks, Deborah Dillon, J.K. Scott et al. · Regulatory Toxicology and Pharmacology · 2012 · 39 citations · Full text
Pharmacy, Environmental Sciences, Toxicology +17
1–5 of 9